Younghac Kim, Eun-Hye Kim, Man Ki Chung, Han-Sin Jeong, Young-Ik Son, Jinyong Kim, Nayeon Choi
{"title":"Clinical Impact of Rapid Recurrence in Oral Tongue Squamous Cell Carcinoma and a Nomogram for Early High-Risk Identification.","authors":"Younghac Kim, Eun-Hye Kim, Man Ki Chung, Han-Sin Jeong, Young-Ik Son, Jinyong Kim, Nayeon Choi","doi":"10.21053/ceo.2026-00007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background.: </strong>This study investigates the effects of various clinical data on rapid recurrence (recurrence within 3months) of oral tongue squamous cell carcinoma (OTSCC) and develops prediction models using various combinations of data.</p><p><strong>Methods.: </strong>We divided 944 OTSCC patients into two groups based on timing of recurrence: the rapid recurrence group (RRG, N=89) and the non-rapid or no-recurrence group (NRRG, N=855). Treatment-related data were collected and analyzed to identify risk factors for overall survival (OS) and rapid recurrence. A logistic regression-based prediction model was developed to identify the likelihood of rapid recurrence, and validation was performed using 10-fold cross-validation, leave-group-out cross-validation, and a calibration plot.</p><p><strong>Results.: </strong>Significantly lower OS rates were identified with increasing age, the T3-4 and N1-3 stages, a higher maximum preoperative positron emission tomography standardized uptake value (PET SUVmax), and rapid recurrence. Among the 89 RRG patients, T2-4 and N3 stages, a positive resection margin, and higher PET SUVmax were significant predictors of rapid recurrence, and postoperative chemoradiation was a preventive factor. A nomogram was developed to facilitate easy prediction of rapid recurrence in real-world clinical practice by risk-stratifying each clinical variable.</p><p><strong>Conclusion.: </strong>Rapid recurrence strongly predicts poor oncologic outcomes in OTSCC. Our validated prediction model, incorporating imaging and pathological factors, might help identify high-risk patients and support more tailored treatment and follow-up strategies.</p>","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2026-00007","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background.: This study investigates the effects of various clinical data on rapid recurrence (recurrence within 3months) of oral tongue squamous cell carcinoma (OTSCC) and develops prediction models using various combinations of data.
Methods.: We divided 944 OTSCC patients into two groups based on timing of recurrence: the rapid recurrence group (RRG, N=89) and the non-rapid or no-recurrence group (NRRG, N=855). Treatment-related data were collected and analyzed to identify risk factors for overall survival (OS) and rapid recurrence. A logistic regression-based prediction model was developed to identify the likelihood of rapid recurrence, and validation was performed using 10-fold cross-validation, leave-group-out cross-validation, and a calibration plot.
Results.: Significantly lower OS rates were identified with increasing age, the T3-4 and N1-3 stages, a higher maximum preoperative positron emission tomography standardized uptake value (PET SUVmax), and rapid recurrence. Among the 89 RRG patients, T2-4 and N3 stages, a positive resection margin, and higher PET SUVmax were significant predictors of rapid recurrence, and postoperative chemoradiation was a preventive factor. A nomogram was developed to facilitate easy prediction of rapid recurrence in real-world clinical practice by risk-stratifying each clinical variable.
Conclusion.: Rapid recurrence strongly predicts poor oncologic outcomes in OTSCC. Our validated prediction model, incorporating imaging and pathological factors, might help identify high-risk patients and support more tailored treatment and follow-up strategies.
期刊介绍:
Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.
CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.
The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.